FR3309M - Nouvelle pipérazine utilisable en thérapeutique, notamment comme antiphlogistique. - Google Patents

Nouvelle pipérazine utilisable en thérapeutique, notamment comme antiphlogistique.

Info

Publication number
FR3309M
FR3309M FR970794A FR970794A FR3309M FR 3309 M FR3309 M FR 3309M FR 970794 A FR970794 A FR 970794A FR 970794 A FR970794 A FR 970794A FR 3309 M FR3309 M FR 3309M
Authority
FR
France
Prior art keywords
antiphlogistic
therapy
new piperazine
piperazine
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR970794A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR961022A external-priority patent/FR1404442A/fr
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR3309M publication Critical patent/FR3309M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR970794A 1963-01-23 1964-04-14 Nouvelle pipérazine utilisable en thérapeutique, notamment comme antiphlogistique. Active FR3309M (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25327063A 1963-01-23 1963-01-23
US31534363A 1963-10-10 1963-10-10
FR961022A FR1404442A (fr) 1963-01-23 1964-01-21 Procédé de préparation de composés pipéraziniques, entre autres de la 1-(2-éthoxy-2-phényléthyl)-4-(2-méthoxy-phényl)-pipérazine

Publications (1)

Publication Number Publication Date
FR3309M true FR3309M (fr) 1965-05-10

Family

ID=26943082

Family Applications (2)

Application Number Title Priority Date Filing Date
FR970794A Active FR3309M (fr) 1963-01-23 1964-04-14 Nouvelle pipérazine utilisable en thérapeutique, notamment comme antiphlogistique.
FR970793A Active FR3308M (fr) 1963-01-23 1964-04-14 Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents anti-inflammatoires.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR970793A Active FR3308M (fr) 1963-01-23 1964-04-14 Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents anti-inflammatoires.

Country Status (7)

Country Link
AT (10) AT247348B (fr)
BE (2) BE642844A (fr)
CH (6) CH446349A (fr)
ES (2) ES295632A1 (fr)
FR (2) FR3309M (fr)
GB (2) GB1047044A (fr)
NL (2) NL6400466A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0102609A3 (en) * 1998-06-30 2002-12-28 Zeria Pharm Co Ltd N-phenyl-n'-phenylpropylpiperazine derivatives and process for the preparation thereof, and pharmaceutical compositions containing them
USD1009638S1 (en) * 2019-06-07 2024-01-02 Seiko Epson Corporation Packaging container
USD979418S1 (en) * 2019-06-28 2023-02-28 Seiko Epson Corporation Packaging container

Also Published As

Publication number Publication date
CH446348A (de) 1967-11-15
AT247346B (de) 1966-06-10
GB1048903A (en) 1966-11-23
AT247347B (de) 1966-06-10
AT247337B (de) 1966-06-10
GB1047044A (en) 1966-11-02
ES295631A1 (es) 1964-07-16
CH446349A (de) 1967-11-15
CH446346A (de) 1967-11-15
CH449629A (de) 1968-01-15
NL6400467A (fr) 1964-07-24
CH446345A (de) 1967-11-15
AT247348B (de) 1966-06-10
NL6400466A (fr) 1964-07-24
BE642844A (fr) 1964-07-22
AT247350B (de) 1966-06-10
ES295632A1 (es) 1964-07-16
CH446347A (de) 1967-11-15
AT247343B (de) 1966-06-10
AT247351B (de) 1966-06-10
AT247342B (de) 1966-06-10
AT247336B (de) 1966-06-10
AT247349B (de) 1966-06-10
BE642845A (fr) 1964-07-22
FR3308M (fr) 1965-05-10

Similar Documents

Publication Publication Date Title
FR3684M (fr) Nouvelle pénicilline.
AT254633B (de) Lager, insbesondere Wälzlager
FR3846M (fr) Nouvelles 4-amino-pipéridines.
DK105902C (da) Metalbor.
FR3439M (fr) Nouvelle quinazoline utilisable en thérapeutique, notamment comme analgésique.
OA00772A (fr) Composition dermatologie.
FR3818M (fr) Nouvel imidazole utilisable en thérapeutique, notamment comme agent antischistosomien et antiamibien.
FR3734M (fr) Nouvelle pipérazine utilisable en thérapeutique, notamment comme agent hypotenseur.
FR3309M (fr) Nouvelle pipérazine utilisable en thérapeutique, notamment comme antiphlogistique.
DK119340B (da) Hurtigt løbende røreværksmølle.
BE647221A (fr) 3,5-dialkyl-4-hydroxy-plenylacetic acid derivatives.
FR3770M (fr) Nouvelles lactones utiles comme agents hypocholestérémiques.
FR3782M (fr) Nouvelle isoquinoléine utilisable en thérapeutique, notamment comme béchique.
FR3805M (fr) Nouvelle &delta<4>-7α-méthyl-17β-hydroxy-19-nor-androstene-3-one utilisable en thérapie.
FR2691M (fr) Nouveaux a-nor-b-homo-stéroides utilisables en thérapeutique, notamment comme gestagenes.
DK113039B (da) Stald.
FR3864M (fr) Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents hypotenseurs.
FR3504M (fr) Nouveau composé de phtalazinium utilisable en thérapeutique, notamment comme vermicide.
DK113507B (da) Kontaktur.
FR3325M (fr) Nouvelles 2-alcoyl-4-pyridine-aldéhyde-thiosemicarbazones.
BE642025A (fr) Nouvelles indolylalcoylguanidines.
FR3552M (fr) Nouvelle association anticoagulante.
OA00280A (fr) Nouvelle composition fongicide.
FR2331M (fr) Nouvelle 2,3-dihydro-benzofuranne utilisable en thérapeutique, notamment comme agent antihypertensif.
FR349M (fr) Nouvelle 1,3-dihydroxy-2-nitro-tricos-4-yne utilisable en thérapeutique.